STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2919 by analyst upside · 2026-06-27
NVST
Envista Holdings Corporation
Healthcare · Market Cap $4B · P/E 64.2x
ANALYST PRICE TARGET
+10.1%
implied upside to consensus target
Current Price $26.96
Consensus Target $29.69
Bull Target $35.0
Bear Target $21.0
Analysts Covering 13
ANALYST CONSENSUS — BUY
Strong Buy
1
Buy
6
Hold
6
Sell
0
52-Week Low $18.77
52-Week High $30.42
YTD Return +24.3%
FUNDAMENTALS
Market Cap $4B
P/E Ratio (TTM) 64.2x
Forward P/E 17.1x
EPS (TTM) $0.42
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $2.8B
Profit Margin 2.4%
52-WEEK RANGE
52-Week Low $18.77
52-Week High $30.42
Current Price $26.96
Bear Target $21.0
Bull Target $35.0
● Now $26.96 ● Target $29.69
TRADING DATA
Avg Volume 3.0M
YTD Return +24.3%
Analyst Count 13
Consensus Buy
Upside to Target +10.1%
Last Updated 2026-06-27

ANALYST SUMMARY

Envista Holdings Corporation (NVST) is currently trading at $26.96 with a Wall Street consensus price target of $29.69, implying potential upside of 10.1% over the next 12 months. 13 analysts currently cover NVST, with a consensus rating of Buy — 54% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $35.0, while the most cautious has a target of $21.0.

NVST operates in the Healthcare sector with a market capitalisation of $4B. The stock is up 24.3% year-to-date and is currently trading near the upper end of its 52-week range of $18.77 – $30.42.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for NVST, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays — Reiterated
Overweight → Overweight 2026-06-11 Building track record
JP Morgan — Reiterated
Neutral → Neutral 2026-05-07 43% win rate (7 calls)
Evercore ISI Group — Reiterated
Outperform → Outperform 2026-05-07 Building track record
Baird — Reiterated
Outperform → Outperform 2026-05-07 Building track record
Morgan Stanley — Reiterated
Equal-Weight → Equal-Weight 2026-04-24 Building track record
Citigroup ● Initiated
Neutral 2026-04-15 Building track record
Evercore ISI Group — Reiterated
Outperform → Outperform 2026-04-08 Building track record
Barclays — Reiterated
Overweight → Overweight 2026-02-11 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
47
out of 100
Coverage depth
20/30
Consensus clarity
20/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →